Skip to main content
Clinical Trials/CTRI/2020/03/024341
CTRI/2020/03/024341Not yet recruitingPhase 2

A Randomized Open Label Clinical Trial On the efficacy of Tiktaka Ghrita Tarpana, Prasadana Putapaka And Kataka Khadiradi Ghan Vati In Madumehajanya Timira With Special Reference To Diabetic Retinopathy

Director National Institute of Ayurveda0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Known cases of Type I and Type II diabetes mellitus
  • 2. Patients with well controlled blood sugar level
  • 3. Patients with visual symptoms like blurring of vision, floaters etc
  • 4. Patients with mild to moderate NPDR
  • 5. Patients willing to give written consent

Exclusion Criteria

  • 1. Patients with severe NPDR or with PDR, Diabetic Maculopathy.
  • 2. Patients with Diabetic Retinopathy with complications like Retinal detachment, posterior vitreal detachment, acute vitreal hemorrhage, RubiosisIridis.
  • 3. Gestational Diabetic Retinopathy.
  • 4. Severe visual impairments like high Myopia, Retinitis Pigmentosa, mature Cataract, post Cataract surgeries, Glaucoma.
  • 5. Patients with other systemic complaints like Hypertension, Renal impairment, COPD, cardiovascular diseases.

Investigators

Sponsor
Director National Institute of Ayurveda

Similar Trials